期刊文献+

广谱全人源化甲型流感病毒中和抗体在流感预防与治疗中的应用

Application of broad-spectrum humanized neutralizing monoclonal antibodies to influenza A virus in prevention and treatment of influenza
原文传递
导出
摘要 针对多个亚型甲型流感病毒的广谱中和性单克隆抗体(monoclonal antibody,mAb)是极具潜力的新型而有效的流感防治手段.抗流感病毒血凝素(hemagglutinin,HA)的保护性mAb,无论通过主动免疫还是被动免疫,均具有很好的效果.迄今,已有不少甲型流感病毒广谱中和性mAb被开发出来.尽管这些mAb具备临床应用潜能以及作为研制新型疫苗(抗独特型抗体疫苗)的可能,但仅有几种HA mAb对人类流感防治真正有效.此文主要对能高效识别多个亚型HA的人源化甲型流感病毒mAb做一综述. Broad-spectrum neutralizing monoclonal antibodies (mAbs) against different subtypes of influenza A viruses are potential tools to prevent and treat influenza.Protective mAbs to influenza hemagglutinin (HA) have good results by passive and active immunization.So far,a number of mAbs against influenza HA have been developed.But only few of them are effective for influenza prevention and treatment.In this article,the human mAbs which can recognize divergent influenza isolates are reviewed.
出处 《国际生物制品学杂志》 CAS 2013年第5期253-256,共4页 International Journal of Biologicals
基金 广西科学研究与技术开发计划项目(桂科合1347004-27)
关键词 抗体 中和 抗体 单克隆 流感病毒A型 表位 Antibodies, neutralizing Antibodies, Monoclonal Influenza A virus Epitopes
  • 相关文献

参考文献39

  • 1Asner S, Peci A, Marchand-Austin A, et al. Respiratory viral infections in institutions from late stage of the first and second waves of pandemic influenza A ( H1 N1 ) 2009, Ontario, Canada [J]. InfItlenza Other Respi Viruses, 2012, 6(3) : e11-15.
  • 2Baird JS, Buet A, Hymes SR, et al. Comparing the clinical severity of the first versus second wave of 2009 Influenza A (H1N1) in a New York City pediatric healthcare facility [ J]. Pediatr Crit Care Med, 2012, 13(4) : 375-380.
  • 3Bauer K, Durrwald R, Schlegel M, et al. Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008 [J].Med Microbiol Immunol, 2012, 201(1) : 61-72.
  • 4Chintakrindi A, Dsouza C, Kanyalkar M. Rational development of neuraminidase inhibitor as novel anti-flu drug [ J]. Mini Rev Med Chem, 2012, 12(12) : 1273-1281.
  • 5Katsunuma T, Matsui T, Iwata T, et al. Hospitalizations associated with pandemic influenza A (H1N1) 2009 in asthmatic children in Japan [J]. Allergol Int, 2012, 61(1):75-82.
  • 6Nguyen HT, Fry AM, Gubareva LV. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods [ J]. Antivir Ther, 2012, 17(1 PtB): 159-173.
  • 7Anar C, Biemen C, Yapicioglu S, et al. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease [ J ]. New microbiol, 2010, 33(2) : 117-127.
  • 8Kitching A, Roche A, Balasegaram S, et al. Oseltamivir adherence and side effects among children in three London schools affected by influenza A ( H1N1 ) v, May 2009 -- an inter'net-based cross- sectional survey [J]. Euro Surveill, 2009, 14(30) : 19287.
  • 9Blondel B, Mahjoub N, Drewniak N, et al. Failure of the vaccination campaign against A (HIN1) influenza in pregnant women in France: results from a national survey [ J]. Vaccine, 2012, 30(38) : 5661-5665.
  • 10Nachtnebel M, Greutelaers B, Falkenhorst G, et al. Lessons from a one-year hospital-based surveillance of acute respiratory infections in Berlin-comparing case definitions to monitor influenza [J]. BMC Public Heahh, 2012, 12: 245.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部